Quarterly report · Q2

Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥9.1bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥16.3bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥8.4bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥1.2bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥1.2bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥1.3bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥2.1bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥1.3bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥1.3bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥848m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.9bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.5bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥926m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥1.5bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥27.5bnat 2022-09-30Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥26.0bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥6.2bnat 2022-09-30Cons.Liabilities
Total liabilities¥5.8bnat 2022-03-31Cons.Liabilities
Net assets / equity¥21.4bnat 2022-09-30Cons.Net assets
Net assets / equity¥20.8bnat 2022-03-31Cons.Net assets
Net assets / equity¥20.5bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥12.9bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥11.9bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥12.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥11.9bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥11.4bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥9.7bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥254m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow¥232m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥432m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥659m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥486m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥568m2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥802m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥110.62022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥250.582021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥187.252021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥101.752021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio73.7%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio74.5%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio75.2%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-09-30¥138m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2022-04-01 → 2022-09-30¥1.1bn
—segment totalrevenue2022-04-01 → 2022-09-30¥9.1bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥9.1bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥1.2bn
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue2021-04-01 → 2021-09-30¥938m
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentrevenue external2021-04-01 → 2021-09-30¥938m
jpcrp040300-q2r_E02333-000Medical Relatedreportable segmentsegment profit2021-04-01 → 2021-09-30¥81m
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue2021-04-01 → 2021-09-30¥7.5bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentrevenue external2021-04-01 → 2021-09-30¥7.5bn
jpcrp040300-q2r_E02333-000Water Health Carereportable segmentsegment profit2021-04-01 → 2021-09-30¥1.1bn
—segment totalrevenue2021-04-01 → 2021-09-30¥8.4bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥8.4bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 503
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember3350580
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.4371
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember582600
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.0760
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember521700
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.0680
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember120000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.0156
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember104617
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.0136
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember101900
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.0132
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember70000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.0091
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember50000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.0065
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember50000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.0065
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember48200
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.0062
Number of shares heldCurrentQuarterInstant4999597
Shareholding ratioCurrentQuarterInstant0.6522
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember991600
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember7660500
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember76605
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember4680
Number of shares issued shares voting rightsCurrentQuarterInstant8656780
Number of voting rights issued shares voting rightsCurrentQuarterInstant76605
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member991600
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member991600
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.1145
Number of shares held in own name treasury shares etcCurrentQuarterInstant991600
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant991600
Shareholding ratio treasury shares etcCurrentQuarterInstant0.1145
Cash and depositsPrior1YearInstant11878323000JPY
Cash and depositsCurrentQuarterInstant12892223000JPY
Notes and accounts receivable tradePrior1YearInstant3861929000JPY
Notes and accounts receivable tradeCurrentQuarterInstant4435426000JPY
Short term investment securitiesPrior1YearInstant502520000JPY
Short term investment securitiesCurrentQuarterInstant-JPY
Finished goodsPrior1YearInstant565610000JPY
Finished goodsCurrentQuarterInstant542157000JPY
Raw materials and suppliesPrior1YearInstant858048000JPY
Raw materials and suppliesCurrentQuarterInstant919709000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass